|
1
|
de Krijger I, Mekenkamp LJM, Punt CJA and
Nagtegaal ID: MicroRNAs in colorectal cancer metastasis. J Pathol.
224:438–447. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Kerjaschki D, Bago-Horvath Z, Rudas M,
Sexl V, Schneckenleithner C, Wolbank S, Bartel G, Krieger S, Kalt
R, Hantusch B, et al: Lipoxygenase mediates invasion of
intrametastatic lymphatic vessels and propagates lymph node
metastasis of human mammary carcinoma xenografts in mouse. J Clin
Invest. 121:2000–2012. 2011. View
Article : Google Scholar : PubMed/NCBI
|
|
3
|
Tentes IK, Schmidt WM, Krupitza G, Steger
GG, Mikulits W, Kortsaris A and Mader RM: Long-term persistence of
acquired resistance to 5-fluorouracil in the colon cancer cell line
SW620. Exp Cell Res. 316:3172–3181. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Senfter D, Holzner S, Kalipciyan M,
Staribacher A, Walzl A, Huttary N, Krieger S, Brenner S, Jäger W,
Krupitza G, et al: Loss of miR-200 family in 5-fluorouracil
resistant colon cancer drives lymphendothelial invasiveness in
vitro. Hum Mol Genet. 24:3689–3698. 2015.PubMed/NCBI
|
|
5
|
Mader RM, Wieser M, Berger W, Kalipciyan
M, Hackl M, Steger GG and Grillari J: Relevance of microRNA
modulation in chemoresistant colon cancer in vitro. Int J Clin
Pharmacol Ther. 49:67–68. 2011.
|
|
6
|
Paterson EL, Kazenwadel J, Bert AG,
Khew-Goodall Y, Ruszkiewicz A and Goodall GJ: Down-regulation of
the miRNA-200 family at the invasive front of colorectal cancers
with degraded basement membrane indicates EMT is involved in cancer
progression. Neoplasia. 15:180–191. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Findlay VJ, Wang C, Watson DK and Camp ER:
Epithelial-to-mesenchymal transition and the cancer stem cell
phenotype: Insights from cancer biology with therapeutic
implications for colorectal cancer. Cancer Gene Ther. 21:181–187.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Sánchez-Martínez R, Cruz-Gil S, Gómez de
Cedrón M, Álvarez-Fernández M, Vargas T, Molina S, García B,
Herranz J, Moreno-Rubio J, Reglero G, et al: A link between lipid
metabolism and epithelial-mesenchymal transition provides a target
for colon cancer therapy. Oncotarget. 6:38719–38736.
2015.PubMed/NCBI
|
|
9
|
Schoppmann SF, Soleiman A, Kalt R, Okubo
Y, Benisch C, Nagavarapu U, Herron GS and Geleff S:
Telomerase-immortalized lymphatic and blood vessel endothelial
cells are functionally stable and retain their lineage specificity.
Microcirculation. 11:261–269. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Nguyen CH, Senfter D, Basilio J, Holzner
S, Stadler S, Krieger S, Huttary N, Milovanovic D, Viola K,
Simonitsch-Klupp I, et al: NF-κB contributes to MMP1 expression in
breast cancer spheroids causing paracrine PAR1 activation and
disintegrations in the lymph endothelial barrier in vitro.
Oncotarget. 6:39262–39275. 2015.PubMed/NCBI
|
|
11
|
Madlener S, Saiko P, Vonach C, Viola K,
Huttary N, Stark N, Popescu R, Gridling M, Vo NT, Herbacek I, et
al: Multifactorial anticancer effects of digalloyl-resveratrol
encompass apoptosis, cell-cycle arrest, and inhibition of
lymphendothelial gap formation in vitro. Br J Cancer.
102:1361–1370. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Loboda A, Nebozhyn MV, Watters JW, Buser
CA, Shaw PM, Huang PS, Van't Veer L, Tollenaar RA, Jackson DB,
Agrawal D, et al: EMT is the dominant program in human colon
cancer. BMC Med Genomics. 4:92011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Yuan D, Xia H, Zhang Y, Chen L, Leng W,
Chen T, Chen Q, Tang Q, Mo X, Liu M, et al: p-Akt/miR 200 signaling
regulates epithelial-mesenchymal transition, migration and invasion
in circulating gastric tumor cells. Int J Oncol. 45:2430–2438.
2014.PubMed/NCBI
|
|
14
|
Vonach C, Viola K, Giessrigl B, Huttary N,
Raab I, Kalt R, Krieger S, Vo TP, Madlener S, Bauer S, et al: NF-κB
mediates the 12(S)-HETE-induced endothelial to mesenchymal
transition of lymphendothelial cells during the intravasation of
breast carcinoma cells. Br J Cancer. 105:263–271. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Myzak MC, Dashwood WM, Orner GA, Ho E and
Dashwood RH: Sulforaphane inhibits histone deacetylase in vivo and
suppresses tumorigenesis in Apc-minus mice. FASEB J. 20:506–508.
2006.PubMed/NCBI
|
|
16
|
Myzak MC, Tong P, Dashwood WM, Dashwood RH
and Ho E: Sulforaphane retards the growth of human PC-3 xenografts
and inhibits HDAC activity in human subjects. Exp Biol Med
(Maywood). 232:227–234. 2007.
|
|
17
|
Ji Q, Liu X, Han Z, Zhou L, Sui H, Yan L,
Jiang H, Ren J, Cai J and Li Q: Resveratrol suppresses
epithelial-to-mesenchymal transition in colorectal cancer through
TGF-β1/Smads signaling pathway mediated Snail/E-cadherin
expression. BMC Cancer. 15:972015. View Article : Google Scholar
|
|
18
|
Larriba MJ, Martín-Villar E, García JM,
Pereira F, Peña C, de Herreros AG, Bonilla F and Muñoz A: Snail2
cooperates with Snail1 in the repression of vitamin D receptor in
colon cancer. Carcinogenesis. 30:1459–1468. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Beltran M, Puig I, Peña C, García JM,
Alvarez AB, Peña R, Bonilla F and de Herreros AG: A natural
antisense transcript regulates Zeb2/Sip1 gene expression during
Snail1-induced epithelial-mesenchymal transition. Genes Dev.
22:756–769. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zheng YB, Luo HP, Shi Q, Hao ZN, Ding Y,
Wang QS, Li SB, Xiao GC and Tong SL: miR-132 inhibits colorectal
cancer invasion and metastasis via directly targeting ZEB2. World J
Gastroenterol. 20:6515–6522. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Meidhof S, Brabletz S, Lehmann W, Preca
BT, Mock K, Ruh M, Schüler J, Berthold M, Weber A, Burk U, et al:
ZEB1-associated drug resistance in cancer cells is reversed by the
class I HDAC inhibitor mocetinostat. EMBO Mol Med. 7:831–847. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Díaz-Martín J, Díaz-López A, Moreno-Bueno
G, Castilla MÁ, Rosa-Rosa JM, Cano A and Palacios J: A core
microRNA signature associated with inducers of the
epithelial-to-mesenchymal transition. J Pathol. 232:319–329. 2014.
View Article : Google Scholar
|
|
23
|
Dashwood RH and Ho E: Dietary histone
deacetylase inhibitors: From cells to mice to man. Semin Cancer
Biol. 17:363–369. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Svehlíková V, Wang S, Jakubíková J,
Williamson G, Mithen R and Bao Y: Interactions between sulforaphane
and apigenin in the induction of UGT1A1 and GSTA1 in CaCo-2 cells.
Carcinogenesis. 25:1629–1637. 2004. View Article : Google Scholar : PubMed/NCBI
|
